Aridis Pharmaceuticals Inc

NASDAQ:ARDS   10:50:00 AM EDT
7.07
+0.24 (+3.54%)
Earnings Announcements

Aridis Pharmaceuticals Posts Q3 Loss Per Share Of $0.65

Published: 11/20/2020 21:14 GMT
Aridis Pharmaceuticals Inc (ARDS) - Aridis Pharmaceuticals Announces Third Quarter 2020 Results.
Q3 Loss per Share $0.65.
Q3 Earnings per Share Estimate $-0.63 -- Refinitiv Ibes Data (analyst estimates).
Aridis Pharmaceuticals - Total Cash and Cash Equivalents As of Sept 30 Was $6.2 Million.
Revenue is expected to be $0.5 Million
Adjusted EPS is expected to be -$0.55

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.